Igm Biosciences, Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Mar. 28, 2024).
In: Pharma Business Week, 2024-04-15, S. 1839
Zeitungsartikel
Zugriff:
Titel: |
Igm Biosciences, Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Mar. 28, 2024).
|
---|---|
Zeitschrift: | Pharma Business Week, 2024-04-15, S. 1839 |
Veröffentlichung: | 2024 |
Medientyp: | Zeitungsartikel |
ISSN: | 1543-6675 (print) |
Sonstiges: |
|